Monthly Archives: October 2023

Infection

Lessons learned from the COVID-19 pandemic. Researchers identify key takeaways for AIDS service organizations to ensure resilience

Posted on by yun
28
Oct

The COVID-19 pandemic overwhelmed health care systems across the United States. More than 100 million cases and one million deaths later, clinicians and researchers are still unraveling the lessons learned from this global public health crisis. In a recent publication in AIDS and Behavior, scientists from the University of South Carolina identified seven lessons regarding […]

Continue reading →
Infection

The SARS-CoV-2 virus can migrate within neurons and infect the brain

Posted on by yun
28
Oct

The emergence of different variants of SARS-CoV-2 has produced a wide range of clinical profiles and symptoms in patients. For the first time, researchers at the Institut Pasteur and Université Paris Cité have demonstrated, in an animal model, a characteristic common to several SARS-CoV-2 variants: the ability to infect the central nervous system. The study […]

Continue reading →
Cancer and neoplasms

Futibatinib by Otsuka Pharmaceutical for Extrahepatic Bile Duct Cancer: Likelihood of Approval

Posted on by yun
28
Oct

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Futibatinib overview Futibatinib (Lytgobi) is an anticancer agent. It is formulated […]

Continue reading →
Cancer and neoplasms

Imetelstat sodium by Geron for Refractory Acute Myeloid Leukemia: Likelihood of Approval

Posted on by yun
28
Oct

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Imetelstat sodium overview Imetelstat (JNJ-63935937) is under development for the treatment […]

Continue reading →
Cancer and neoplasms

Breast cancer: Not necessarily a death sentence, but a costly battle

Posted on by yun
28
Oct

CAGAYAN DE ORO, Philippines – The breast cancer journey is complex at all levels, spanning from diagnosis to how people respond to it, their capacity to afford treatment, the support system, the battle against mental health challenges, the palliative care, and continuing until the end of care. Mercelita “Merci” Jandayan-Labial, a graduate school professor at […]

Continue reading →